Jane A. Mitchell

24.4k total citations · 6 hit papers
268 papers, 19.1k citations indexed

About

Jane A. Mitchell is a scholar working on Physiology, Pharmacology and Biochemistry. According to data from OpenAlex, Jane A. Mitchell has authored 268 papers receiving a total of 19.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Physiology, 92 papers in Pharmacology and 78 papers in Biochemistry. Recurrent topics in Jane A. Mitchell's work include Inflammatory mediators and NSAID effects (91 papers), Nitric Oxide and Endothelin Effects (83 papers) and Eicosanoids and Hypertension Pharmacology (77 papers). Jane A. Mitchell is often cited by papers focused on Inflammatory mediators and NSAID effects (91 papers), Nitric Oxide and Endothelin Effects (83 papers) and Eicosanoids and Hypertension Pharmacology (77 papers). Jane A. Mitchell collaborates with scholars based in United Kingdom, United States and Qatar. Jane A. Mitchell's co-authors include Timothy D. Warner, John R. Vane, Christoph Thiemermann, Ferid Murad, Pravit Akarasereenont, David Bishop‐Bailey, Ulrich Förstermann, Ivana Vojnovic, Masaki Nakane and R.J. Flower and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jane A. Mitchell

263 papers receiving 18.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

1993 1.4k citations Jane A. Mitchell, Christoph Thiemermann et al. Proceedings of the National Academy of Sciences profile →
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis

1999 1.3k citations Timothy D. Warner, Ivana Vojnovic et al. Proceedings of the National Academy of Sciences profile →
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

1994 919 citations Jane A. Mitchell, David Bishop‐Bailey et al. Proceedings of the National Academy of Sciences profile →
The safety and side effects of monoclonal antibodies

2010 821 citations Trevor T. Hansel, Jane A. Mitchell et al. profile →
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.

1991 817 citations Jane A. Mitchell, Timothy D. Warner et al. Proceedings of the National Academy of Sciences profile →
Isoforms of nitric oxide synthase Characterization and purification from different cell types

1991 716 citations Jane A. Mitchell, Timothy D. Warner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane A. Mitchell United Kingdom	66	5.9k	5.4k	4.6k	3.0k	2.9k	268	19.1k
Timothy D. Warner United Kingdom	58	6.3k 1.1×	3.5k 0.6×	3.9k 0.9×	2.4k 0.8×	4.1k 1.4×	252	15.5k
Christoph Thiemermann United Kingdom	84	7.1k 1.2×	2.5k 0.5×	7.8k 1.7×	3.7k 1.2×	2.7k 0.9×	434	26.1k
Thomas M. Coffman United States	72	2.5k 0.4×	3.7k 0.7×	6.4k 1.4×	1.8k 0.6×	6.6k 2.3×	253	20.3k
Colin Funk United States	65	3.2k 0.5×	4.7k 0.9×	6.8k 1.5×	3.5k 1.1×	1.0k 0.4×	183	17.6k
Giuseppe Cirino Italy	72	4.7k 0.8×	2.4k 0.4×	5.5k 1.2×	6.0k 2.0×	1.6k 0.5×	288	17.9k
Mark G. Currie United States	63	5.2k 0.9×	1.7k 0.3×	4.6k 1.0×	1.6k 0.5×	2.6k 0.9×	219	17.0k
Philip Needleman United States	72	4.1k 0.7×	6.1k 1.1×	6.0k 1.3×	4.4k 1.5×	5.7k 1.9×	263	20.8k
Paresh Dandona United States	81	5.0k 0.8×	2.6k 0.5×	5.2k 1.1×	894 0.3×	3.6k 1.2×	496	25.2k
John L. Wallace Canada	99	6.6k 1.1×	7.9k 1.5×	7.3k 1.6×	8.2k 2.7×	1.5k 0.5×	446	34.1k
Lucas Liaudet Switzerland	66	4.0k 0.7×	2.0k 0.4×	4.5k 1.0×	1.2k 0.4×	3.4k 1.1×	224	18.2k

Countries citing papers authored by Jane A. Mitchell

Since Specialization

Citations

This map shows the geographic impact of Jane A. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Mitchell more than expected).

Fields of papers citing papers by Jane A. Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Mitchell. The network helps show where Jane A. Mitchell may publish in the future.

Co-authorship network of co-authors of Jane A. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Jane A. Mitchell. A scholar is included among the top collaborators of Jane A. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane A. Mitchell. Jane A. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marei, Isra, Blerina Ahmetaj‐Shala, Omar Chidiac, et al.. (2023). Altered Gene Expression and Impaired Repair Functions of Circulating Endothelial Colony-Forming Cells From Diabetic Patients. SHILAP Revista de lepidopterología. 4. 100169–100169. 1 indexed citations

May, James M., Jane A. Mitchell, & Gísli Jenkins. (2023). Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. Journal of Clinical Investigation. 133(18). 43 indexed citations

Pires, Maria Elisa Lopes, Paul C. Armstrong, Blerina Ahmetaj‐Shala, et al.. (2023). Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Arteriosclerosis Thrombosis and Vascular Biology. 44(1). 271–286. 5 indexed citations

MacIntyre, I., Emma Turtle, Tariq E. Farrah, et al.. (2022). Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 145(6). 416–423. 30 indexed citations

Shih, Chih‐Chin, Melissa V. Chan, Nicholas S. Kirkby, et al.. (2021). Platelet inhibition by P2Y₁₂ antagonists is potentiated by adenosine signalling activators. British Journal of Pharmacology. 178(23). 4758–4771. 9 indexed citations

Vaja, Ricky, Jeffrey Shi Kai Chan, Amer Harky, et al.. (2020). The COVID‐19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections. British Journal of Clinical Pharmacology. 87(3). 776–784. 20 indexed citations

Paul‐Clark, Mark J., Saffron A.G. Willis‐Owen, Miriam F. Moffatt, et al.. (2019). EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype. Scientific Reports. 9(1). 9218–9218. 17 indexed citations

Lucotti, Serena, Camilla Cerutti, Magali Soyer, et al.. (2019). Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2. Journal of Clinical Investigation. 129(5). 1845–1862. 156 indexed citations

Mitchell, Jane A. & Nicholas S. Kirkby. (2018). Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. British Journal of Pharmacology. 176(8). 1038–1050. 154 indexed citations

10.

Kirkby, Nicholas S., et al.. (2018). Abstract 16362: The Right Heart is Specifically Targeted by Intravenous Administration of Treprostinil: Implications for Our Understanding of How Prostacyclin Drugs Work to Treat Pulmonary Arterial Hypertension. Circulation. 1 indexed citations

11.

Mitchell, Jane A., Blerina Ahmetaj‐Shala, Jing Jiao, et al.. (2017). Abstract 18520: Novel Tissue-specific Cyclooxygenase-1 Knockout Mice Demonstrate a Dominant Role for Endothelial Cyclooxygenase-1 in Prostacyclin Production. Circulation. 1 indexed citations

12.

Armstrong, Paul C., Jane A. Mitchell, Timothy D. Warner, et al.. (2015). Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach. BMJ Open. 5(1). e005750–e005750. 1 indexed citations

13.

Kojonazarov, Baktybek, Himal Luitel, Akylbek Sydykov, et al.. (2013). The Peroxisome Proliferator–Activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy. Pulmonary Circulation. 3(4). 926–935. 19 indexed citations

14.

Kirkby, Nicholas S., Martina H. Lundberg, Melissa V. Chan, et al.. (2013). Blockade of the purinergic P2Y ₁₂ receptor greatly increases the platelet inhibitory actions of nitric oxide. Proceedings of the National Academy of Sciences. 110(39). 15782–15787. 44 indexed citations

15.

Pathan, Nazima, Margarita Burmester, Maurice Berk, et al.. (2011). Intestinal Injury and Endotoxemia in Children Undergoing Surgery for Congenital Heart Disease. American Journal of Respiratory and Critical Care Medicine. 184(11). 1261–1269. 47 indexed citations

16.

Kapoor, Amar, Yasunori Shintani, Massimo Collino, et al.. (2010). Protective Role of Peroxisome Proliferator–activated Receptor-β/δ in Septic Shock. American Journal of Respiratory and Critical Care Medicine. 182(12). 1506–1515. 65 indexed citations

17.

Paul‐Clark, Mark J., Shaun K. McMaster, Rosalinda Sorrentino, et al.. (2008). Toll-like Receptor 2 Is Essential for the Sensing of Oxidants during Inflammation. American Journal of Respiratory and Critical Care Medicine. 179(4). 299–306. 46 indexed citations

18.

Cartwright, Neil, Oliver Murch, Shaun K. McMaster, et al.. (2007). Selective NOD1 Agonists Cause Shock and Organ Injury/Dysfunction in Vivo. American Journal of Respiratory and Critical Care Medicine. 175(6). 595–603. 54 indexed citations

19.

Mitchell, Jane A., et al.. (1998). The Role of Endogenous Nitric Oxide in Modulating Ischemia-Reperfusion Injury in the Isolated, Blood-perfused Rat Lung. American Journal of Respiratory and Critical Care Medicine. 157(1). 273–279. 33 indexed citations

20.

Griffiths, Mark, Nick Curzen, Jane A. Mitchell, & Timothy W. Evans. (1997). In Vivo Treatment with Endotoxin Increases Rat Pulmonary Vascular Contractility Despite NOS Induction. American Journal of Respiratory and Critical Care Medicine. 156(2). 654–658. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact